URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Muthusamy Shanmugam net worth and biography

Muthusamy Shanmugam Biography and Net Worth

Head of R&D and COO of ANI Pharmaceuticals

Mr. Shanmugam is the Head of R&D and COO of NJ Operations and a member of ANI’s Board. Mr. Shanmugam joined ANI in Nov. 2021 through ANI's acquisition of Novitium Pharma, where he was the President and Founder. With over 30 years of experience in the Generic Pharmaceutical Industry, he has led Novitium Pharma LLC in getting 30+ generic approvals, since its inception in 2016. His R&D focus and regulatory knowledge has resulted in Novitium Pharma having an industry leading, average time to approval of 13 months, for ANDA submissions. Prior to Novitium Pharma LLC, his entrepreneurialism has led him to founding Edict Pharmaceuticals, Ethics Biolabs, and Nuray Chemicals Pvt. Ltd. Over the span of his career, he has developed and successfully received approval for 100+ Generic Drug products, focusing on efficiencies such as vertical integration with CRO’s and API manufacturing facilities. Mr. Samy has consistently exceeded investor expectations while innovating the field of Generic Pharmaceutical Development. Mr. Samy is a Licensed Pharmacist in the State of New York and has a Master's Degree in Pharmaceutics from JSS College of Pharmacy.

How old is Muthusamy Shanmugam?: Mr. Shanmugam is currently 56 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Muthusamy Shanmugam's age.
How do I contact Muthusamy Shanmugam?: The corporate mailing address for Mr. Shanmugam and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Muthusamy Shanmugam's contact information.
Has Muthusamy Shanmugam been buying or selling shares of ANI Pharmaceuticals?: Muthusamy Shanmugam has not been actively trading shares of ANI Pharmaceuticals during the past quarter. Learn More on Muthusamy Shanmugam's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Thomas Haughey (Director), Nikhil Lalwani (Pres), Muthusamy Shanmugam (Head of R&D and COO), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 39 times. They sold a total of 388,462 shares worth more than $24,698,415.22. The most recent insider tranaction occured on December, 17th when CFO Stephen P Carey sold 7,500 shares worth more than $418,425.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 12/17/2024.

Muthusamy Shanmugam Insider Trading History at ANI Pharmaceuticals

Muthusamy Shanmugam Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $53.35

$53.00

$54.56

50 Day Range

MA: $57.85

$53.35

$61.74

2 Week Range

Now: $53.35

$52.00

$70.81

Volume

1,066,257 shs

Average Volume

225,876 shs

Market Capitalization

$1.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now